| Latest Eirx Therapeutics News Headlines |
| Date | Time | Source | |
| 08/21/2008 | 5:47AM | TFNF | Billam writes off investment in EiRx Therapeutics
Billam Plc. said it has decided to write off
its investment in EiRx Therapeutics Plc. after the announcement on Wednesday
that EiRx has called in liquidators for its Irish unit.
In total, the group's investment portfolio has therefore been reduced by
433,000 pounds when also taking into account the company's... More...>> |
| 08/20/2008 | 12:32PM | TFNF | EiRx Therapeutic applies to put Irish unit into liquidation
EiRx Therapeutics Plc. said Wednesday it is
applying to put its wholly-owned Irish subsidiary Eirx Therapeutics Ltd. into
liquidation.
As a result of this, the group's chief executive Colin Telfer has been made
redundant and has resigned as a director of the company with immediate effect.
It further... More...>> |
| 08/20/2008 | 12:04PM | UKREG | Resignation of Director, Liquidation of subsidiary
RNS Number : 7588B
EiRx Therapeutics PLC
20 August 2008
Eirx Therapeutics plc ("the Company")
Resignation of Director, Liquidation of subsidiary
Eirx Therapeutics plc announced today that it is applying to put its wholly owned Irish subsidiary Eirx Therapeutics Limited.("ETL")
into liquidation... More...>> |
| 07/15/2008 | 7:01AM | TFNF | EiRx Therapeutic shares suspended on AIM; says bankers have withdrawn support
EiRx Therapeutics Plc. said Tuesday it has
requested a suspension of trading in its shares on AIM pending clarification of
its financial position.
It said its bankers have declined to provide the replacement 350,000-pound
facility despite Billam AG having agreed to extend its guarantee to 350,000
pounds... More...>> |
| 07/15/2008 | 6:30AM | UKREG | Statement re. Suspension
RNS Number : 0821Z
EiRx Therapeutics PLC
15 July 2008
15 July 2008
EiRx Therapeutics plc ("EiRx" or "the Company")
Update on financial position
The Company announced on 19 February 2008 a funding package designed to give the Company working capital for twelve months. The
components of... More...>> |
| 07/15/2008 | 6:30AM | UKREG | Suspension - EiRx Therapeutics plc
RNS Number : 0822Z
AIM
15 July 2008
NOTICE
(490)
15/07/2008 11:30am
TEMPORARY SUSPENSION OF TRADING ON AIM
EIRX THERAPEUTICS PLC
At the request of the company trading on AIM for the under-mentioned securities has been... More...>> |
| 07/07/2008 | 10:33AM | UKREG | Holding(s) in Company
RNS Number : 4893Y
EiRx Therapeutics PLC
07 July 2008
Financial Services Authority
TR-1 i: NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Identity of the issuer or Eirx Therapeutics Plc
the underlying
issuer of existing shares to
which
voting rights are attached ii:
2... More...>> |
| 07/03/2008 | 4:10AM | UKREG | Update on Medicinal Chemistry Collaboration
RNS Number : 2229Y
EiRx Therapeutics PLC
03 July 2008
EIRX THERAPEUTICS PLC
("EiRx" or "the Company")
Update on medicinal chemistry collaboration with University College Cork
Cork, Ireland - EiRx Therapeutics plc (AIM: ERX), the drug discovery company developing targeted therapies... More...>> |
| 07/02/2008 | 5:37AM | UKREG | Issue of Equity
RNS Number : 1209Y
EiRx Therapeutics PLC
02 July 2008
EIRX THERAPEUTICS PLC
("EiRx" or "the Company")
Admission of shares
Application has been made for the admission of 1,577,333,333 EiRx ordinary shares of 0.001p with admission expected to take place on 4
July 2008.
The shares... More...>> |
| 06/17/2008 | 7:19AM | UKREG | Result of EGM
RNS Number : 9020W
EiRx Therapeutics PLC
17 June 2008
EIRX THERAPEUTICS PLC
("the Company")
17 June 2008
Result of Extraordinary General Meeting
At the Extraordinary General Meeting of the Company held earlier today, all resolutions were passed.
For further information... More...>> |
| 05/23/2008 | 1:14PM | UKREG | Notice of EGM
RNS Number : 2333V
EiRx Therapeutics PLC
23 May 2008
EIRX THERAPEUTICS PLC
( "EiRx" or "the Company" )
Notice of Extraordinary General Meeting
Cork, Friday 23rd May 2008:
On 19 February, the Company stated that it intended to hold a general meeting at which shareholders would be asked... More...>> |
| 04/18/2008 | 8:12AM | UKREG | Holding(s) in Company
EiRx Therapeutics PLC
18 April 2008
Financial Services Authority
TR-1 i: NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Identity of the issuer or the underlying Eirx Therapeutics Plc
issuer of existing shares to which
voting rights are attached ii:
2. Reason... More...>> |
| 04/08/2008 | 11:41AM | UKREG | Holding(s) in Company
EiRx Therapeutics PLC
08 April 2008
Financial Services Authority
TR-1 i: NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Identity of the issuer or the underlying Eirx Therapeutics Plc
issuer of existing shares to which
voting rights are attached ii:
2. Reason... More...>> |
| 04/08/2008 | 5:16AM | UKREG | Holding(s) in Company
EiRx Therapeutics PLC
08 April 2008
Financial Services Authority
TR-1 i: NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Identity of the issuer or the underlying Eirx Therapeutics Plc
issuer of existing shares to which
voting rights are attached ii:
2. Reason... More...>> |
| 04/02/2008 | 9:04AM | UKREG | Holding(s) in Company
EiRx Therapeutics PLC
02 April 2008
Financial Services Authority
TR-1 i: NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Identity of the issuer or the underlying Eirx Therapeutics Plc
issuer of existing shares to which
voting rights are attached... More...>> |
| 04/01/2008 | 7:42AM | UKREG | Holding(s) in Company
EiRx Therapeutics PLC
01 April 2008
Financial Services Authority
TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Identity of the issuer or the underlying issuer of Eirx Therapeutics Plc
existing shares to which voting rights are attached:
2. Reason for notification (please... More...>> |
| 03/28/2008 | 1:47PM | TFNF | EiRx Therapeutics H1 pretax loss narrows on lower admin costs
EiRx Therapeutics PLC posted a narrower first
half pretax loss on lower administrative expenses and said it is reviewing
options including partnering with larger businesses and merger and acquisitions
opportunities for product development.
The drug discovery company developing targeted therapies for cancer... More...>> |
| 03/28/2008 | 1:07PM | UKREG | Interim Results
EiRx Therapeutics PLC
28 March 2008
EIRX THERAPEUTICS PLC
("EiRx" or "the Company")
INTERIM RESULTS - SIX MONTHS ENDED 31 DECEMBER 2007
Cork, Ireland - EiRx Therapeutics plc (AIM: ERX), the drug discovery company
developing... More...>> |
| 03/13/2008 | 5:22AM | TFNF | EiRx Therapeutics closes Aberdeen facility, moves Auvation unit to Cork UPDATE
(Adds further detail)
EiRx Therapeutics PLC said it is closing its
Aberdeen facility this month and relocating the operations of its Auvation unit
to Cork, as part of efforts to streamline its organisation and focus expenditure
on critical activities.
The drug discovery company said the activities affected... More...>> |
| 03/13/2008 | 3:58AM | TFNF | EiRx Therapeutic to close Aberdeen facility; moving Auvation unit to Cork
EiRx Therapeutics PLC said it is closing the
Aberdeen facility this month and relocating the operations of its Auvation unit
to Cork.
The drug discovery company said these activities include the cancer
biomarker effort undertaken in collaboration with BioMerieux SA, and revenue
generation from licensing... More...>> |